Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Validation of a Mail-In Delayed Semen Analysis Protocol Developed for Home Collection

American Society of Reprdouctive Health

ASRM 2023

New Orleans, LA October 14-18, 2023

Oral presentation: Validation of a mail-in delayed semen analysis protocol developed for home collection

Authors: Racicot K, Jenkins C, Datta V, Leader B

Specialty: Women's Health, OB/GYN

Related content

Publication
Evolution of Specimen Self-Collection in the COVID-19 Era: Implications for Population Health Management of Infectious Disease
Publication
Highly atherogenic lipid particles are associated with preeclampsia after successful fertility treatment for obese women who have unexplained infertility
Conference Presentation
Highly atherogeneic lipid particles are associated with preeclampsia (Pre-E) in obese women with unexplained infertility who conceived during ovarian stimulation with intrauterine insemination (OS-IUI)

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.